Modulation of cardiac aldosterone synthase and type I mineralocorticoid receptor expression in experimental chronic heart failure

被引：0
作者：
Christ, M
Kellner, M
Wehling, M
Lombés, M
Fraccarollo, D
Ertl, G
Bauersachs, J
机构：
[1] Klinikum Mannheim, Inst Clin Pharmacol, Mannheim, Germany
[2] Fac Med Xavier Bichat, INSERM, U478, Paris, France
[3] Med Universitatsklin, Wurzburg, Germany
来源：
EUROPEAN HEART JOURNAL | 2000年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1362
引用
收藏
页码：251 / 251
页数：1
相关论文
共 50 条
[41]   Differential mortality risk prediction by aldosterone and cortisol in systolic heart failure with versus without mineralocorticoid receptor blockade [J].
Guder, G. ;
Hammer, F. ;
Brenner, S. ;
Berliner, D. ;
Deutschbein, T. ;
Fassnacht, M. ;
Allolio, A. ;
Ertl, G. ;
Angermann, C. E. ;
Stoerk, S. .
EUROPEAN HEART JOURNAL, 2013, 34 :285-285
[42]   Assessment of aldosterone synthase (CYP11B2), mineralocorticoid receptor expression and markers of fetal cardiac gene reprogramming in rats exposed to fine particles [J].
Morales-Rubio, R. ;
Uribe-Ramirez, M. ;
Aztatzi-Aguilar, O. ;
De Vizcaya-Ruiz, A. .
TOXICOLOGY LETTERS, 2016, 259 :S76-S77
[43]   Role of aldosterone in coronary and peripheral endothelial dysfunction assessed in rats with heart failure or mice with cardiac specific overexpression of aldosterone synthase [J].
Favre, J ;
Vercauteren, M ;
Nehme, J ;
Mellin, V ;
Delcayre, C ;
Di Meglio, B ;
Henry, JP ;
Jeng, AY ;
Webb, RL ;
Richard, V ;
Mulder, P ;
Thuillez, C .
CIRCULATION, 2005, 112 (17) :U318-U318
[44]   Aldosterone receptor antagonists induce favorable cardiac remodeling in diastolic heart failure patients [J].
Orea-Tejeda, Arturo ;
Colin-Ramirez, Eloisa ;
Castillo-Martinez, Lilia ;
Asensio-Lafuente, Enrique ;
Corzo-Leon, Dora ;
Gonzalez-Toledo, Rafael ;
Rebollar-Gonzalez, Veronica ;
Narvaez-David, Rene ;
Dorantes-Garcia, Joel .
REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2007, 59 (02) :103-107
[45]   Distinct mechanisms of modulation of angiotensin II type I receptor gene expression in heart and aorta [J].
Wang, DH ;
Yao, A ;
Zhao, HW ;
DiPette, DJ .
HYPERTENSION, 1997, 29 (05) :1104-1108
[46]   Modulation of cardiac contractility in patients with chronic heart failure and atrial fibrillation [J].
Uskach, T. M. ;
Safiullina, A. A. ;
Sapel'nikov, O., V ;
Amanatova, V. A. ;
Nikolaeva, O. A. ;
Grishin, I. R. ;
Nazarov, B. M. ;
Tereshchenko, S. N. .
TERAPEVTICHESKII ARKHIV, 2020, 92 (09) :8-14
[47]   CARDIAC CONTRACTILITY MODULATION: AN OPTION FOR CHRONIC HEART FAILURE; A CASE REPORT [J].
Lamaida, N. ;
Cerciello, A. .
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2024, 26 :ii134-ii134
[48]   Cardiac contractility modulation improves cardiac function in a rabbit model of chronic heart failure [J].
Zhang, Fei-Fei ;
Qi, Xiao-Yong ;
Li, Ying-Xiao ;
Dang, Yi ;
Liu, Hui-Liang ;
Yuan, Hua-Bing ;
Li, Rong .
BIOMEDICAL RESEARCH-INDIA, 2017, 28 (04) :1894-1899
[49]   Mineralocorticoid receptor antagonists in heart failure patients with chronic kidney disease: why, when, and how? [J].
Kassem, Hania ;
Chatila, Khaled .
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2020, 29 (02) :258-263
[50]   Influence of background treatment with mineralocorticoid receptor antagonists on ivabradines effects in patients with chronic heart failure [J].
Komajda, Michel ;
Boehm, Michael ;
Borer, Jeffrey ;
Ford, Ian ;
Krum, Henry ;
Tase, Adrian ;
Tavazzi, Luigi ;
Swedberg, Karl .
EUROPEAN JOURNAL OF HEART FAILURE, 2013, 15 (01) :79-84
12345